Type
Form D Funds
Date
Sold
AUM
VC
Cycle Venture Partners Fund I LP - Cytoveris Series 4
[2024-03-27]
0.5 M
0.5 M
Filed 2023-07-26 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Lumeda Series 3
[2023-03-22]
1.3 M
Offered $5,000,000 · Filed 2022-07-15 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining $5,000,000 · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cybrexa Series
[2022-03-22]
2.1 M
3.1 M
Filed 2017-06-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cybrexa Series 2
[2022-03-22]
2.1 M
5.4 M
Filed 2017-06-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cybrexa Series 3
[2022-03-22]
5.2 M
7.1 M
Filed 2020-02-03 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cybrexa Series 4
[2022-03-22]
3.5 M
17.4 M
Offered $3,495,000 · Filed 2021-01-11 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cytoveris Series 1
[2022-03-22]
2.1 M
1.0 M
Filed 2017-06-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cytoveris Series 2
[2022-03-22]
2.8 M
0.8 M
Filed 2020-05-05 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Cytoveris Series 3
[2022-03-22]
3.5 M
2.2 M
Offered $5,000,000 · Filed 2021-11-12 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $50,000 · Remaining $1,460,000 · Duration One year or less · Revenue Decline to Disclose
VC
Cycle Venture Partners Fund I LP - Lumeda Series 1
[2022-03-22]
0.4 M
0.3 M
Offered $435,500 · Filed 2020-06-08 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
View All